- Home
- ITCI vs FFIV Comparison
ITCI vs FFIV Comparison
Compare ITCI & FFIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- FFIV
- Stock Information
- Founded
- ITCI 2002
- FFIV 1996
- Country
- ITCI United States
- FFIV United States
- Employees
- ITCI N/A
- FFIV N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- FFIV Computer Communications Equipment
- Sector
- ITCI Health Care
- FFIV Telecommunications
- Exchange
- ITCI Nasdaq
- FFIV Nasdaq
- Market Cap
- ITCI 13.5B
- FFIV 14.8B
- IPO Year
- ITCI N/A
- FFIV 1999
- Fundamental
- Price
- ITCI $126.97
- FFIV $299.16
- Analyst Decision
- ITCI Buy
- FFIV Hold
- Analyst Count
- ITCI 13
- FFIV 10
- Target Price
- ITCI $103.62
- FFIV $289.00
- AVG Volume (30 Days)
- ITCI 5.8M
- FFIV 675.7K
- Earning Date
- ITCI 02-20-2025
- FFIV 01-28-2025
- Dividend Yield
- ITCI N/A
- FFIV N/A
- EPS Growth
- ITCI N/A
- FFIV 31.07
- EPS
- ITCI N/A
- FFIV 10.05
- Revenue
- ITCI $613,728,000.00
- FFIV $2,890,012,000.00
- Revenue This Year
- ITCI $48.43
- FFIV $6.78
- Revenue Next Year
- ITCI $38.10
- FFIV $3.79
- P/E Ratio
- ITCI N/A
- FFIV $29.83
- Revenue Growth
- ITCI 46.08
- FFIV 3.02
- 52 Week Low
- ITCI $62.78
- FFIV $159.01
- 52 Week High
- ITCI $128.00
- FFIV $308.00
- Technical
- Relative Strength Index (RSI)
- ITCI 84.04
- FFIV 72.38
- Support Level
- ITCI $126.88
- FFIV $287.57
- Resistance Level
- ITCI $127.36
- FFIV $301.02
- Average True Range (ATR)
- ITCI 0.44
- FFIV 7.44
- MACD
- ITCI -0.90
- FFIV 2.87
- Stochastic Oscillator
- ITCI 55.86
- FFIV 82.29
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About FFIV F5 Inc.
F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.